Skip to main content

I 13.5 (Pemazyre 13.5 mg)

Generic Name: pemigatinib

Pill with imprint I 13.5 is White, Round and has been identified as Pemazyre 13.5 mg. It is supplied by Incyte Corporation.

Pemazyre is used in the treatment of cholangiocarcinoma of biliary tract and belongs to the drug class multikinase inhibitors. Pemazyre 13.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for I 13.5

Pemazyre

Generic Name
pemigatinib
Imprint
I 13.5
Strength
13.5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Incyte Corporation
National Drug Code (NDC)
50881-0028

Get help with Imprint Code FAQs.

Related Images for "I 13.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.